You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 October 2024 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday that it has entered into a strategic partnership with Orano Med, a developer of targeted alphatherapies in oncology and a subsidiary of th...
17 October 2024 - New York-based longevity science company Elysium Health Inc announced on Wednesday that it has introduced VISION by Elysium Health for eye longevity, performance, and protection.The product was developed with the guidance of Theodor...
17 October 2024 - Clinical-stage biotechnology company IgGenix Inc announced on Wednesday that the first patient has been dosed in its ACCELERATE Peanut Phase 1 clinical trial of IGNX001, a novel therapeutic candidate developed using IgGenix's p...
17 October 2024 - US-based global healthcare company Viatris Inc (Nasdaq:VTRS) announced on Wednesday that it has signed an exclusive licensing agreement with biopharmaceutical company Lexicon Pharmaceuticals Inc (Nasdaq:LXRX).The agreement is for th...
17 October 2024 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX: 01801) announced on Wednesday that a phase 2 clinical study of picankibart (R&D code: IBI112), a recombinant anti-interleukin 23p19 subunit (IL-23p19) antibody inje...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe